{"context":{"query":">>efo>>gwas_study","source_dataset":"efo","target_dataset":"gwas_study"},"stats":{"queried":1,"total":50,"mapped":1},"pagination":{"has_next":false},"schema":"id|disease_trait|first_author|journal|publication_date","mappings":[{"input":"EFO:0000756","source":"EFO:0000756|melanoma","targets":["GCST000198|Melanoma|Brown KM|Nat Genet|2008-05-18","GCST000437|Melanoma|Bishop DT|Nat Genet|2009-07-05","GCST001129|Melanoma|Teerlink C|Hum Genet|2011-06-26","GCST001245|Melanoma|Amos CI|Hum Mol Genet|2011-09-22","GCST001266|Melanoma|Macgregor S|Nat Genet|2011-10-09","GCST001267|Melanoma|Barrett JH|Nat Genet|2011-10-09","GCST001886|Melanoma|Iles MM|Nat Genet|2013-03-03","GCST002514|Melanoma|Song F|Carcinogenesis|2014-06-30","GCST004142|Melanoma|Ransohoff KJ|Oncotarget|2017-02-09","GCST90011809|Melanoma|Rashkin SR|Nat Commun|2020-09-04","GCST90027057|Melanoma|Brandes N|Sci Rep|2021-07-21","GCST90041914|Cancer code, self-reported: malignant melanoma (UKB data field 20001_1059)|Jiang L|Nat Genet|2021-11-04","GCST90043866|ICD10 C43.3: Malignant melanoma of other and unspecified parts of face|Jiang L|Nat Genet|2021-11-04","GCST90043867|ICD10 C43.5: Malignant melanoma of trunk|Jiang L|Nat Genet|2021-11-04","GCST90043868|ICD10 C43.6: Malignant melanoma of upper limb, including shoulder|Jiang L|Nat Genet|2021-11-04","GCST90043869|ICD10 C43.7: Malignant melanoma of lower limb, including hip|Jiang L|Nat Genet|2021-11-04","GCST90043870|ICD10 C43.9: Malignant melanoma of skin, unspecified|Jiang L|Nat Genet|2021-11-04","GCST90043916|ICD10 D03.3: Melanoma in situ of other and unspecified parts of face|Jiang L|Nat Genet|2021-11-04","GCST90043917|ICD10 D03.5: Melanoma in situ of trunk|Jiang L|Nat Genet|2021-11-04","GCST90043918|ICD10 D03.6: Melanoma in situ of upper limb, including shoulder|Jiang L|Nat Genet|2021-11-04","GCST90043919|ICD10 D03.7: Melanoma in situ of lower limb, including hip|Jiang L|Nat Genet|2021-11-04","GCST90077638|Malignant melanoma (UKB data field 20001)|Backman JD|Nature|2021-10-18","GCST90079089|Malignant melanoma of trunk (UKB data field 40006)|Backman JD|Nature|2021-10-18","GCST90079090|Malignant melanoma of upper limb, including shoulder (UKB data field 40006)|Backman JD|Nature|2021-10-18","GCST90079091|Malignant melanoma of lower limb, including hip (UKB data field 40006)|Backman JD|Nature|2021-10-18","GCST90079092|Malignant melanoma of skin (UKB data field 40006)|Backman JD|Nature|2021-10-18","GCST90079126|Melanoma in situ (UKB data field 40006)|Backman JD|Nature|2021-10-18","GCST90079591|ICD10 C43.6: Malignant melanoma of upper limb, including shoulder|Backman JD|Nature|2021-10-18","GCST90079592|ICD10 C43.7: Malignant melanoma of lower limb, including hip|Backman JD|Nature|2021-10-18","GCST90079644|ICD10 D03: Melanoma in situ|Backman JD|Nature|2021-10-18","GCST90081624|Malignant melanoma (UKB data field 20001) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083075|Malignant melanoma of trunk (UKB data field 40006) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083076|Malignant melanoma of upper limb, including shoulder (UKB data field 40006) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083077|Malignant melanoma of lower limb, including hip (UKB data field 40006) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083078|Malignant melanoma of skin (UKB data field 40006) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083112|Melanoma in situ (UKB data field 40006) (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083577|ICD10 C43.6: Malignant melanoma of upper limb, including shoulder (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083578|ICD10 C43.7: Malignant melanoma of lower limb, including hip (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90083630|ICD10 D03: Melanoma in situ (Gene-based burden)|Backman JD|Nature|2021-10-18","GCST90094985|Melanoma x citrus consumption interaction (2df)|Marley AR|Int J Cancer|2021-11-01","GCST90103972|Melanoma|Liyanage U|J Invest Dermatol|2021-11-20","GCST90132200|Survival in melanoma|Pflugfelder A|Cancers (Basel)|2022-05-13","GCST90137504|Melanoma specific survival|Seviiri M|J Transl Med|2022-09-05","GCST90141010|Overall survival in skin melanoma|Xin J|Nucleic Acids Res|2022-08-10","GCST90141027|Skin melanoma specific survival|Xin J|Nucleic Acids Res|2022-08-10","GCST90468141|Malignant melanoma|Loya H|Nat Genet|2025-01-09","GCST90503280|Malignant melanoma (Gene-based burden)|Wilcox N|Am J Hum Genet|2025-03-07","GCST90558252|Melanoma in situ|Ingold N|JAMA Dermatol|2024-08-14","GCST90558253|Invasive melanoma|Ingold N|JAMA Dermatol|2024-08-14","GCST90558254|Melanoma (in situ vs invasive)|Ingold N|JAMA Dermatol|2024-08-14"]}]}